Pharmaceutical Technology
May 02, 2011
News
35
5
Eastern Europe's pharmaceutical leader, Hungary, is working to maintain its number-one status while also pursuing new avenues, especially in biopharmaceuticals.
May 02, 2011
Packaging Forum
35
5
Visitors found new container options, child-resistant concepts, and serialization solutions. This article contains bonus online material.
May 02, 2011
Outsourcing Outlook
35
5
Lessons from the earthquake in Japan show the vulnerability of the bio/pharma supply chain.
May 02, 2011
In the Spotlight
35
5
Editor's picks of analytical instrumentation products for May 2011.
May 02, 2011
Special Report
35
5
Regulators and standard-setting bodies are re-examining over-the-counter drugs.
May 02, 2011
Peer-Reviewed Research
35
5
The authors develop a pratical approach to avoid unwanted interactions between pepsin and SLS in dissolution Tier II tests.
May 02, 2011
Industry Leader
35
5
Greg Irace, president of sanofi-aventis, on recent industry trends.
May 02, 2011
Peer-Reviewed Research
35
5
The authors examine the influence of glass-transition temperature, melt viscosity, degradation temperature, and process settings.
May 02, 2011
News
35
5
Efforts are made to educate health workers in less developed countries.
May 02, 2011
Special Report
35
5
Emerging methods could provide alternative ways of producing inhalable drug particles.
May 02, 2011
Pharma Ingredients
35
5
Approaches in using small-molecule and peptide synthesis offer promise in widening the scope of drug candidates.
May 02, 2011
Pharma Ingredients
35
5
Nanosponges, a controlled-release nanoparticle system, shows promise in targeted drug delivery
May 02, 2011
From The Editor
35
5
Those who doubt there's faith in science, should check out our annual Bioprocessing Survey.
May 02, 2011
Washington Report
35
5
FDA, NIH and industry seek new strategies to spur drug development and promote access to therapies.
May 02, 2011
PharmTech Talk
35
5
Can the semiconductor industry help Big Pharma develop therapies?
May 02, 2011
Inside USP
35
5
Monograph modernization and standards donation go hand in hand.
May 02, 2011
BioForum
35
5
Innovator and generic-drug companies need to adapt to compete in the biosimilars market.
May 02, 2011
Viewpoint
35
5
India has the potential to become the new star of the biotechnology industry.
May 02, 2011
Book Review
35
5
Students and professionals can learn a good deal from a review of single-use technology.